79 related articles for article (PubMed ID: 15090836)
1. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program.
Massad LS; Seaberg EC; Watts DH; Hessol NA; Melnick S; Bitterman P; Anastos K; Silver S; Levine AM; Minkoff H
AIDS; 2004 Jan; 18(1):109-13. PubMed ID: 15090836
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer incidence after up to 20 years of observation among women with HIV.
Massad LS; Hessol NA; Darragh TM; Minkoff H; Colie C; Wright RL; Cohen M; Seaberg EC
Int J Cancer; 2017 Oct; 141(8):1561-1565. PubMed ID: 28670714
[TBL] [Abstract][Full Text] [Related]
3. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.
Dorrucci M; Suligoi B; Serraino D; Tirelli U; Rezza G;
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):377-80. PubMed ID: 11317082
[TBL] [Abstract][Full Text] [Related]
4. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
[TBL] [Abstract][Full Text] [Related]
5. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
[TBL] [Abstract][Full Text] [Related]
6. Risk of invasive cervical cancer among women with, or at risk for, HIV infection.
Serraino D; Carrieri P; Pradier C; Bidoli E; Dorrucci M; Ghetti E; Schiesari A; Zucconi R; Pezzotti P; Dellamonica P; Franceschi S; Rezza G
Int J Cancer; 1999 Jul; 82(3):334-7. PubMed ID: 10399949
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
8. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients.
Chin KM; Sidhu JS; Janssen RS; Weber JT
Obstet Gynecol; 1998 Jul; 92(1):83-7. PubMed ID: 9649099
[TBL] [Abstract][Full Text] [Related]
9. Long-term incidence of cervical cancer in women with human immunodeficiency virus.
Massad LS; Seaberg EC; Watts DH; Minkoff H; Levine AM; Henry D; Colie C; Darragh TM; Hessol NA
Cancer; 2009 Feb; 115(3):524-30. PubMed ID: 19127538
[TBL] [Abstract][Full Text] [Related]
10. Impact of HIV infection on invasive cervical cancer in Kenyan women.
Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
[TBL] [Abstract][Full Text] [Related]
11. Support for down-staging of pregnancy-associated cervical cancer.
Kärrberg C; Rådberg T; Holmberg E; Norström A
Acta Obstet Gynecol Scand; 2015 Jun; 94(6):654-9. PubMed ID: 25845736
[TBL] [Abstract][Full Text] [Related]
12. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
14. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection in women infected with the human immunodeficiency virus.
Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
17. HIV-seropositive pregnant women: a high-risk group for cervical SIL.
Coppolillo EF; Peluffo M
Acta Cytol; 1998; 42(4):1058-9. PubMed ID: 9684610
[No Abstract] [Full Text] [Related]
18. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
